☆ 4.7 Article

Great Expectations of COVID-19 Herd Immunity

MBIO (2022)

Related references

Note: Only part of the references are listed.

Letter Medicine, General & Internal

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

Fabian Schmidt et al.

Summary: Neutralization assays showed much lower omicron neutralization compared to Wuhan-hu-1 after two doses of mRNA vaccine, but individuals who received a booster vaccine or were vaccinated after recovering from Covid-19 exhibited high levels of omicron neutralization.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa

Hiroshi Nishiura et al.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Review Medicine, General & Internal

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic A Systematic Review

Daniel P. Oran et al.

Summary: Available data suggests that at least one third of SARS-CoV-2 infections are asymptomatic. Longitudinal studies indicate that nearly three quarters of individuals who test positive via PCR but show no symptoms at the time of testing will remain asymptomatic. Control strategies for COVID-19 need to be adjusted considering the prevalence and transmission risk of asymptomatic SARS-CoV-2 infections.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Alicia T. Widge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

Lindsey R. Baden et al.

Summary: Participants who had previously received placebo in the trial were offered the mRNA-1273 vaccine in the open-label phase. The incidence of Covid-19 in this group was lower than those who had been vaccinated earlier, showing a modest decrease in vaccine efficacy over time.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralizing Activity of BNT162b2-Elicited Serum

Yang Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley et al.

Summary: The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Antibody, B cell, and T cell responses decline over the first 4 months post-infection, while S-specific IgG(+) memory B cells consistently accumulate. The study suggests that natural infection may only provide transient protection at a population level, highlighting the need for more immunogenic and durable vaccines.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medicine, General & Internal

Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers

Yoel Angel et al.

Summary: This cohort study in Tel Aviv, Israel, found that vaccination with the Pfizer-BioNTech BNT162b2 vaccine was significantly associated with a lower incidence of symptomatic and asymptomatic SARS-CoV-2 infection among health care workers more than 7 days after the second dose.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Immunology

Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses

Joshua G. Petrie et al.

Summary: Reinfection with seasonal HCoVs is frequent, and binding anti-spike protein antibodies do not correlate with protection from seasonal HCoV infection, with little cross-response to SARS-CoV-2 proteins.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity

Muthukumar Ramanathan et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Population density and basic reproductive number of COVID-19 across United States counties

Karla Therese L. Sy et al.

Summary: The study found that there is an association between population density and R-0 of SARS-CoV-2, with higher population density counties having higher transmission rates. A population density threshold of 22 people/km(2) was needed to sustain an outbreak, and each increase in one unit of log population density increased R-0 by 0.16.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimating the basic reproduction number for COVID-19 in Western Europe

Isabella Locatelli et al.

Summary: Despite the possible unreliability of some official statistics about COVID-19, the spread of the disease appears to be remarkably similar in most European countries, allowing for an estimated average R-0 in Western Europe of 2.2. The value of R-0 for COVID-19 in Western Europe seems to be significantly lower than that in China, with a lower proportion of immune persons in the European population needed to stop the outbreak.

PLOS ONE (2021)

Add to Collection

Editorial Material Oncology

How will emerging SARS-CoV-2 variants impact herd immunity?

Giuseppe Lippi et al.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Confronting the Delta Variant of SARS-CoV-2, Summer 2021

Carlos del Rio et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus

Ying Liu et al.

Summary: The Delta variant is rapidly replacing other strains of SARS-CoV-2, with a higher R-0 value of 5.08 compared to the ancestral strain's 2.79. Increasing vaccine coverage and strengthening public health measures are now more urgent than ever to control the spread of the virus.

JOURNAL OF TRAVEL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel

T. Pilishvili et al.

Summary: The BNT162b2 and mRNA-1273 vaccines were highly effective in preventing symptomatic Covid-19 in U.S. health care personnel, with vaccine effectiveness of 77.6% to 96.3%. The effectiveness was consistent across different subgroups defined by age, race and ethnic group, underlying conditions, and patient contact levels, indicating the vaccines were effective for preventing Covid-19 in those at risk and in disproportionately affected groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

H. M. El Sahly et al.

Summary: The mRNA-1273 vaccine demonstrated high efficacy in preventing COVID-19 illness and severe disease, with more than 5 months of protection and a good safety profile, including protection against asymptomatic infection.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Health Care Sciences & Services

SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg

Paul Wilmes et al.

Summary: Luxembourg implemented a mass screening programme to accompany the lifting of COVID-19 lockdown measures, covering a significant portion of the population and identifying cases in various sectors and regions. Asymptomatic carriers pose a significant risk for transmission, emphasizing the importance of early testing and high participation rates.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Immunology

Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and Universal Vaccine Development

Matthew J. Memoli et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Infectious Diseases

Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak

Shi Zhao et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Immunology

Herd Immunity: Understanding COVID-19

Haley E. Randolph et al.

IMMUNITY (2020)

Add to Collection

Article Immunology

Universal coronavirus vaccines: the time to start is now

Luca T. Giurgea et al.

NPJ VACCINES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Seasonal coronavirus protective immunity is short-lasting

Arthur W. D. Edridge et al.

NATURE MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis

Zachary J. Madewell et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Multidisciplinary Sciences

A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

Tom Britton et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Vaccine-Derived Polioviruses

Cara C. Burns et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

Add to Collection

Article Immunology

Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands

R. Bodewes et al.

CLINICAL AND VACCINE IMMUNOLOGY (2011)

Add to Collection

Article Immunology

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Geoffrey J. Gorse et al.

CLINICAL AND VACCINE IMMUNOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Duration of humoral immunity to common viral and vaccine antigens

Ian J. Amanna et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.